GENE 润色咨询

GENE

出版年份:1976 年文章数:9384 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:2.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2024-02-19 ms1000001927724256 来自广东省

    with editor 20天了……TT

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2024-03-15 国统乃我辈之愿 来自海南省

    2..12投稿,2.13reviewer invited。一个多月了,还是这状态。

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2024-01-23 ms8000000649093531 来自陕西省

    with editor两周了,是不是被拒的节奏

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2023-11-13 ms4000001562073595 来自吉林省

    偏重的研究方向:分子生物学;基因表达;Meta分析
    经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2023-12-01 ms1000001534810860 来自陕西省

    20231018 Submit to the Journal - With editor
    20231024 Under review
    20231106 Required Reviews Complete
    20231106 Decision in Process – 修回
    20231121 Revisions - With editor
    20231122 Under review
    20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题
    20231128 Revisions - With editor
    20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定
    20231201 Accept

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2024-03-04 维新Tuo1887878 来自广西

    审稿速度:3.0 | 投稿命中率:95.0
    偏重的研究方向:基因
    经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2024-02-20 ms2000001601003991 来自广东省

    一直重复invited咋回事

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2024-02-18 ms7000001263360888 来自广东省

    偏重的研究方向:生物信息
    经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2024-02-13 国统乃我辈之愿 来自海南省

    一般几个审稿人?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2188211, encodeId=502a2188211dc, content=with editor 20天了……TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59c15452322, createdName=ms1000001927724256, createdTime=Mon Feb 19 23:05:26 CST 2024, time=2024-02-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193309, encodeId=4aa42193309c1, content=2..12投稿,2.13reviewer invited。一个多月了,还是这状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Fri Mar 15 08:14:17 CST 2024, time=2024-03-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2183442, encodeId=401e218344244, content=with editor两周了,是不是被拒的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Tue Jan 23 14:55:44 CST 2024, time=2024-01-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2168362, encodeId=171221683629e, content=偏重的研究方向:分子生物学;基因表达;Meta分析<br>经验分享:想问一下,小修返稿后,现在显示with editor,会不会再次送外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a505683452, createdName=ms4000001562073595, createdTime=Mon Nov 13 23:57:14 CST 2023, time=2023-11-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2172395, encodeId=cf3121e239535, content=20231018 Submit to the Journal - With editor<br>20231024 Under review<br>20231106 Required Reviews Complete<br>20231106 Decision in Process – 修回<br>20231121 Revisions - With editor<br>20231122 Under review<br>20231127 We are pleased to inform you that your paper should become acceptable for publication. – 另一个编辑有两个小问题<br>20231128 Revisions - With editor<br>20231201 Decision in Process – 主编发邮件问qPCR是否有问题,当天就发邮件确定<br>20231201 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a789017997, createdName=ms1000001534810860, createdTime=Fri Dec 01 20:03:09 CST 2023, time=2023-12-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190937, encodeId=694e219093e0f, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:基因<br>经验分享:投稿前跟这本期刊的审稿人聊了一下,基本上没有什么问题就直接提交投稿了,不到三个月就下Accept了,效率很快,有什么问题的都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:52:51 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188343, encodeId=dea321883434b, content=一直重复invited咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82c5713283, createdName=ms2000001601003991, createdTime=Tue Feb 20 16:56:30 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188058, encodeId=7d4d21880589b, content=偏重的研究方向:生物信息<br>经验分享:有点无语,投的生信以没有做验证为理由拒稿,然而无论是标题还是摘要都着重写了验证部分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a38173164, createdName=ms7000001263360888, createdTime=Sun Feb 18 22:49:56 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187197, encodeId=70ea218e19781, content=一般几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Feb 13 22:26:33 CST 2024, time=2024-02-13, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2166810, encodeId=fcb421668109c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:基因<br>经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验<br>2023.8.17投稿<br>2023.8.30编辑让补wb全膜图,重新提交<br>2023.9.2外审<br>2023.10.11大修<br>2023.10.26修回<br>2023.10.27再外审<br>2023.11.3接收<br>从投稿到接收历时4个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0c8268365, createdName=ms1000001328024350, createdTime=Sun Nov 05 15:44:45 CST 2023, time=2023-11-05, status=1, ipAttribution=广西)]
    2023-11-05 ms1000001328024350 来自广西

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:基因
    经验分享:分享一下我的投稿经验,希望有所帮助,文章是关于miRNA调控基因的,有pcr、wb等实验
    2023.8.17投稿
    2023.8.30编辑让补wb全膜图,重新提交
    2023.9.2外审
    2023.10.11大修
    2023.10.26修回
    2023.10.27再外审
    2023.11.3接收
    从投稿到接收历时4个半月

    4

    展开4条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分